Related Experiment Video
Updated: Dec 28, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to
Qi Zhong1, Yufeng Zou1, Hongchao Liu1,2
1Department of Anesthesiology, Zhongnan Hospital, Wuhan University, East Lake Road, Wuhan, 430071, Hubei, China.
Abstract:
Toll-like receptor 4 (TLR4) is a crucial receptor in neuroinflammation and apoptotic neuronal death, and increasing evidences indicated that β2-microglobulin (B2M) is thought to be a major contributor to age-related cognitive decline. In present study, we designed to investigate the effects of TLR4 on B2M-induced age-related cognitive decline. Wild-type (WT) C57BL/6, TLR4 knockout (TLR4 -KO) mice and hippocampal neurons from the two type mice were respectively divided into two groups: (1) Veh group; (2) B2M-treated group. The behavioral responses of mice were measured using Morris Water Maze. Hippocampal neurogenesis and neuronal damage, inflammatory response, apoptosis, synaptic proteins and neurotrophic factors, and TLR4/MyD88/NF-κB signaling pathway proteins were examined using molecular biological or histopathological methods. The results showed that WT mice received B2M in the DG exhibited age-related cognitive declines, increased TLR4 mRNA expression and high levels of interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α) and apoptotic neuronal death in the hippocampus, which were partially attenuated in TLR4-KO mice. Moreover, in absence of TLR4, B2M treatment improved hippocampus neurogenesis and increased synaptic related proteins. Our cell experiments further demonstrated that deletion of TLR4 could significantly increase synaptic related protein, decrease neuroinflammatory fators, inhibited apoptotic neuronal death, and regulated MyD88/NF-κB signal pathway after B2M treatment. In summary, our results support the TLR4 contributes to B2M-induced age-related cognitive decline due to neuroinflammation and apoptosis through TLR4/MyD88/NF-κB signaling pathway via a modulation of hippocampal neurogenesis and synaptic function. This may provide an important neuroprotective mechanism for improving age-related cognitive decline.
Insights
Toll-like receptor 4 (TLR4) exacerbates cognitive decline caused by β2-microglobulin (B2M) through neuroinflammation and apoptosis. Blocking TLR4 may offer a neuroprotective strategy against age-related cognitive impairment.
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- β2-microglobulin (B2M) is implicated in age-related cognitive decline.
- Toll-like receptor 4 (TLR4) plays a role in neuroinflammation and neuronal apoptosis.
Purpose of the Study:
- To investigate the role of TLR4 in B2M-induced age-related cognitive decline.
- To explore the underlying mechanisms involving neuroinflammation, apoptosis, and synaptic function.
Main Methods:
- Utilized wild-type and TLR4 knockout mice, treated with B2M or vehicle.
- Assessed cognitive function using the Morris Water Maze.
- Analyzed hippocampal neurogenesis, neuronal damage, inflammation, apoptosis, synaptic proteins, and the TLR4/MyD88/NF-κB pathway.
Main Results:
- B2M induced cognitive decline, neuroinflammation, and apoptosis in wild-type mice, effects attenuated in TLR4 knockout mice.
- TLR4 deletion improved hippocampal neurogenesis and synaptic protein levels after B2M treatment.
- Cell experiments confirmed TLR4's role in B2M-induced neuroinflammation, apoptosis, and pathway regulation.
Conclusions:
- TLR4 contributes to B2M-induced age-related cognitive decline via neuroinflammation and apoptosis.
- The TLR4/MyD88/NF-κB pathway mediates these effects by modulating hippocampal neurogenesis and synaptic function.
- Targeting TLR4 presents a potential neuroprotective strategy for age-related cognitive impairment.

